USE OF FPT INHIBITORS AND AT LEAST TWO ANTINEOPLASTIC AGENTSIN THE TREATMENT OF CANCER

摘要

Disclosed is a use of an FPT inhibitor for the manufacture of a medicament f or the treatment of cancer (e.g., non small cell lung cancer, squamous cell cancer of the head and neck, CML, AML, non-Hodgkin's lymphoma and multiple myeloma), said treatment comprising the administration of said medicament an d therapeutically effective amounts of one or more antineoplastic agents.